593 related articles for article (PubMed ID: 27879277)
21. Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion.
Khosravi S; Wong RP; Ardekani GS; Zhang G; Martinka M; Ong CJ; Li G
Br J Cancer; 2014 Jan; 110(2):399-408. PubMed ID: 24178756
[TBL] [Abstract][Full Text] [Related]
22. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
23. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
[TBL] [Abstract][Full Text] [Related]
24. Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.
Tsang FH; Au V; Lu WJ; Shek FH; Liu AM; Luk JM; Fan ST; Poon RT; Lee NP
Dig Dis Sci; 2014 Oct; 59(10):2477-87. PubMed ID: 24811246
[TBL] [Abstract][Full Text] [Related]
25. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.
Luan W; Ding Y; Yuan H; Ma S; Ruan H; Wang J; Lu F; Bu X
J Exp Clin Cancer Res; 2020 May; 39(1):96. PubMed ID: 32466797
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
28. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM
PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
[TBL] [Abstract][Full Text] [Related]
29. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
30. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
[TBL] [Abstract][Full Text] [Related]
31. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
[TBL] [Abstract][Full Text] [Related]
32. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
33. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
[TBL] [Abstract][Full Text] [Related]
34. EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo.
Wei JH; Cao JZ; Zhang D; Liao B; Zhong WM; Lu J; Zhao HW; Zhang JX; Tong ZT; Fan S; Liang CZ; Liao YB; Pang J; Wu RH; Fang Y; Chen ZH; Li B; Xie D; Chen W; Luo JH
Br J Cancer; 2014 Apr; 110(7):1767-77. PubMed ID: 24504366
[TBL] [Abstract][Full Text] [Related]
35. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
36. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
37. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
[TBL] [Abstract][Full Text] [Related]
38. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
39.
Li Y; Lin S; Li L; Tang Z; Hu Y; Ban X; Zeng T; Zhou Y; Zhu Y; Gao S; Deng W; Zhang X; Xie D; Yuan Y; Huang P; Li J; Cai Z; Guan XY
Cancer Res; 2018 Aug; 78(16):4471-4481. PubMed ID: 29967258
[TBL] [Abstract][Full Text] [Related]
40. [Timeless promotes the proliferation of hepatocellular carcinoma cell by reprogramming of glucose metabolism].
Zhang JS; Yuan P; Yan ZY; Lu R; Li B; Geng XE; Mu J; Zhang HX
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):499-505. PubMed ID: 30060357
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
